News
The new program includes streamlined services for car removal Sydney customers, giving Sydney residents an easier and greener ...
In July 2025, Novartis Pharmaceuticals announced a phase III study to assess efficacy and safety of crizanlizumab (5 mg/kg) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results